The inhibitory effect offour basic aflatoxins on interferon induction by influenza virus in LLC-MK2 cell monolayers follows a structure-activity series with decreasing potency in the order aflatoxin B.>G1>B2-G2. Of the four aflatoxins, B1 was the most deleterious to both cell growth and the viability of cells in confluent cultures. The fact that higher levels of influenza virus growth were attained in aflatoxin-treated cells than in normal cell monolayers was related to increased aflatoxin concentration in association with decreased interferon production. The ability of interferon to confer cellular resistance against viral infection, however, was not altered by aflatoxin. The inhibitory activity of aflatoxin on interferon production may be a factor contributing to impairment of host resistance to viral infections.
Information available on mycotoxin-induced changes of immunity and impairment of resistance to disease has been obtained largely from studies with aflatoxins, a group of closely related, secondary toxic metabolites produced by certain strains of Aspergillus. Aflatoxins have been reported to decrease significantly serum complement activity (21, 36) , decrease or impair phagocytosis (26) , increase susceptibility to and mortality from certain infectious agents (8, 17) , interfere with acquired resistance (23) , or inhibit cellular immune processes (24, 29) . However, considerable variation of these effects on immunity have been encountered which, in part, may be the consequence of various animal species metabolizing diverse mycotoxins at different rates (22) . The major effects of mycotoxins on immunological mechanisms, however, appear to be related to nonspecific humoral factors and to cellular aspects of immunity (27) .
The interferon system is an important component of the host's defense mechanism. The belief prevails that the biological significance of interferon must be greater than that of a mere antiviral substance (28) . Although first described as an antiviral protein, interferon is now considered to be a group of glycoproteins of diverse cellular origins which may also inhibit proliferation of normal and malignant cells and regulate or modulate various aspects of the immune response (9) . Steroids, hormones, carcinogenic hydrocarbons, arsenicals, metals, mineral dust, asbestos fibers, and bacteriocins have been reported to affect interferon synthesis adversely (5, 7, 10-13, 16, 34, 37) . To our knowledge, the in vitro activity of mycotoxins on the interferon system has not been investigated. This report describes studies related to the effect of aflatoxins on viral interferon induction and virus multiplication.
MATERIALS AND METHODS
Viruses. The A,/PR8/8/34 influenza and parainfluenza 1 (Sendai) virus strains employed in this study were obtained from the American Type Culture Collection, Rockville, Md. Stock virus pools of each strain were prepared from embryonated chicken eggs in the manner described previously (14) . Influenza and Sendai virus pools contained 107 and 109 cell-infecting units of virus per ml, respectively, when assayed by the immunofluorescent cell-counting procedure (14) .
Cell cultures. Rhesus monkey kidney (LLC-MK2) and human Chang conjunctival (clone 1-5c-4) cell lines obtained from the American Type Culture Collection were used for induction and assay of interferon, respectively. Cell lines were propagated in plastic tissue culture flasks (25 (20) . Controls consisting of cell monolayers which were not treated with aflatoxin were handled exactly as described above.
Interferon assay. Samples of interferon were assayed in duplicate. An immunofluorescent cell-counting assay of interferon that has been described previously (15) was computed by dividing interferon titers from aflatoxin-treated LLC-MK2 cell cultures by control interferon titer of 315 (ICDD5o) and subtracting from 100%. By using analysis of variance (arc sine transformation) we noted the following significant differences: B1>B2 and G2, G1>G2 (P < 0.01); B.>Gl, G.>B2 (P < 0.05); B2>G2 Although not as effective as 1 ,ug of AFB1, 1 ,ug of the other aflatoxins was also capable of depressing interferon yields. AFG1, however, was more active than either AFB2 or AFG2 in diminishing interferon production. Statistical analysis of the inhibitory activity of the four aflatoxins on interferon production showed ranking with decreasing potency in the order aflatoxin B,>G,>B2 G2.
The inhibition of interferon production was dependent on the sequence of aflatoxin and viral inducer administration onto cell monolayers. A series of experiments was performed to obviate the possibility that diminished interferon production might be the consequence of aflatoxin activity on virus infectivity, interferon degradation, or the induction of a subtle interferon antagonist. Aflatoxin did not affect integrity or the ability of influenza virus to infect cells. When virus was assayed in the presence of either AFB1, -B2, -G1, or -G2, at concentrations that ranged from 100 to 0.1 jug of aflatoxin, all virus assay values showed less than a twofold difference as compared with that of controls. The findings also imply that neither the adsorption process of virus to cells, including virus attachment and penetration, nor the ability of virus to multiply in cells were impeded by aflatoxins.
Interferon potency was not adversely affected by aflatoxin. When interferon of known titer was mixed with AFB1, ranging in quantities from 10 to 100 ytg, or with control medium, assays of the preparations revealed no decline in interferon potency.
That the interaction of aflatoxin with cell monolayers might result in the formation of an interferon antagonist was investigated. This could account for the low levels of interferon noted. To test this, equal volumes of maintenance medium or undiluted low-titer interferon preparations obtained from aflatoxin-treated cell cultures were added to interferon preparations of known potency. The mixtures were then assayed for interferon activity. The potency of the known interferon preparation was not diminished under these conditions, indicating the absence of an interferon antagonist.
Experiments designed to study the replication of influenza virus concomitant with interferon production in both untreated and AFB1 (50I,g)-treated cells revealed similar rates of virus growth (Fig. 1) . However, virus multiplied to a level that was approximately fourfold higher in AFB,-treated cells than in untreated control cells. Minimal amounts of interferon were detected in AFB,-treated cells, whereas as high as 88 ICDD50 units of interferon per ml was obtained from untreated cells. In subsequent experiments, the levels of virus multiplication in cells treated with 10 ,ug or 1 ,jg of AFB1 were only twofold higher or less, respectively, than that in control cell cultures. Interferon yields increased correspondingly. The maximal level of virus growth achieved in cell cultures treated with 50 ,ug of AFG1 was only twofold higher than in untreated cultures. These data suggest that the higher level of virus multiplication attained in aflatoxin-treated cell cultures was dependent on the concentration of aflatoxin and its capacity to depress interferon production.
To determine whether aflatoxin could alter the response of cells to the protection afforded by interferon against virus infection, an interferon preparation of known potency was assayed in the usual manner on clone 1-5c-4 cell monolayers that had been pretreated 20 h earlier with 100 ,ug of either AFBI, AFG1, or the appropriate control medium. Results revealed that interferon assay values of 105 and 100 ICDDso per ml for AFB, and AFG,, respectively, were attained. These values were similar to that of the control, 107 ICDD50 per ml. The process by which resistance is conferred by interferon was not apparently impaired by these aflatoxins.
DISCUSSION
The capacities of the aflatoxins to depress influenza virus-induced interferon in cell cultures were demonstrated in this study. The inhibitory effect on interferon production followed a structure-activity series with decreasing potency in the order aflatoxin B1>G.>B2-G2. The designated order of biological activity is in general agreement with previous demonstrations relative to aflatoxin toxicity (acute) in animals and in cell cultures, altered biochemical processes in vitro, mutagenicity, and carcinogenicity (1-3, 33). It has been substantiated that both the dihydrofurofuran moiety and cyclopentenone ring are important determinants of aflatoxin biological activity (3, 6, 25) . The varied biological effects induced by different aflatoxin derivatives is attributed to alterations of these structures. This circumstance may also account for the capacities of different aflatoxin derivatives to depress viral interferon induction.
Early virus-cell interactions were not impaired by aflatoxin. When influenza virus was assayed by using cells previously treated with either of the four aflatoxins, virus assay values were comparable to those of controls. The implication is that the integrity of cell membranes in relation to the process of virus integration (attachment and penetration) into cells was not adversely affected by the presence of aflatoxin. In subsequent experiments, virus growth rates in aflatoxin-treated and normal cells were comparable, but the levels of virus concentration attained were from two-to fourfold higher in cell cultures previously treated with aflatoxin. The magnitude of virus growth was related to the concentration and the capacities of aflatoxin derivatives to depress interferon production. This phenomenon of enhanced viral growth linked to the inhibitory activity of a carcinogen, i.e., AFB, on interferon production, has been demonstrated also with other carcinogenic agents (5, 16, 37) .
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resistance against viral infection was not impaired when cells were pretreated with aflatoxin.
In the interferon-treated cell, virus protein synthesis is inhibited while the majority of host protein syntheses are apparently unaffected (32, 37) . The process by which interferon confers cellular resistance, presently considered to be the inhibition of the translation of viral ribonucleic acid (RNA) in the interferon-treated cell (18), apparently was not deterred by aflatoxin. Protein synthesis is a requisite for viral interferon production. Inhibition of protein synthesis through transcriptional and translational processes, as well as inhibition of nucleic acid synthesis by affecting the transcription process, is a biochemical effect induced by AFBI and AFG, (3) . Depending on the concentration and the aflatoxin derivative, we have shown that viral interferon synthesis may be partially or almost completely inhibited. One microgram of aflatoxin was able to limit interferon production. Less than 1 ,ug of aflatoxin has been reported to inhibit cell growth or to induce diverse cell abnormalities (4, 19, 38) . Although the mechanism is unknown, aflatoxin may exert its adverse effect on interferon induction through (i) the formation of the inducing molecule, (ii) activation or depression of the interferon gene, or (iii) the transcription and translation of the interferon messenger RNA. The latter may be the more likely possibility in view of the inhibitory activity of aflatoxin on RNA synthesis.
Despite the inhibitory effects attributed to aflatoxin on certain macromolecular activities of host cells, we demonstrated that virus infectivity and viral replication were unaffected by the presence of aflatoxin. Possible explanations for this phenomenon may reside in the multiplication of influenza virus which differs from that of most other RNA viruses in its sensitivity to various inhibitors and the diverse activity of inhibitors under experimental conditions. For example, known inhibitors of protein and RNA syntheses, i.e., cycloheximide and 1-fi-D-ribofuranosylbenzimidazole, have been shown to induce interferon synthesis in cell cultures (38) . Inhibition of protein synthesis has been demonstrated in rat liver preparations exposed in vitro to aflatoxins. However, when the process was studied in vivo, the toxin inhibited the synthesis of only a few specific proteins (inducible enzymes), and total liver protein synthesis appeared to be largely unaffected (38) . Actinomycin D has no apparent effect on the in vitro activities of the influenza virion-or cell-associated polymerases, but in vivo this reagent as well as other inhibitors of cell deoxyribonucleic acid function may block transcription (31). Emon August 27, 2017 by guest http://aac.asm.org/ Downloaded from phasis has been placed upon the parallelism between the biochemical actions of AFB1 and actinomycin D in inhibition of nuclear RNA synthesis, in vitro binding of deoxyribonucleic acid, and inhibition of enzyme induction. The significant similarities in action of the two compounds, however, does not imply that they act through analogous mechanisms or that all of the biochemical effects of AFB1 can be attributed to those pathways apparently shared by both substances (38) . Studies with other inhibitors and physical treatment of cells indicate that a functional cell nucleus or a deoxyribonucleic aciddependent host function, or both, is needed for the multiplication of influenza viruses, but this function has not been identified (30) . Some of the puzzling aspects of aflatoxin activity on hostcell functions as well as gaps in our knowledge concerning the role of the host cell in the initiation and maintenance of influenza virus RNA synthesis need to be resolved to explain influenza virus multiplication in aflatoxin-treated cells.
